These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23963060)

  • 1. A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depression.
    Frye MA; Ebbert JO; Prince CA; Lineberry TW; Geske JR; Patten CA
    J Clin Psychopharmacol; 2013 Dec; 33(6):821-3. PubMed ID: 23963060
    [No Abstract]   [Full Text] [Related]  

  • 2. Varenicline reduced smoking behaviour in a mentally ill person.
    Ochoa EL
    J Psychopharmacol; 2009 May; 23(3):340-1. PubMed ID: 18562426
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for patients. Does varenicline help people with depression quit smoking?
    Ann Intern Med; 2013 Sep; 159(6):I-36. PubMed ID: 24042380
    [No Abstract]   [Full Text] [Related]  

  • 4. Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis.
    Zeng F; Chen CI; Mastey V; Zou KH; Harnett J; Patel BV
    Am J Manag Care; 2010 Sep; 16(9):667-74. PubMed ID: 20873954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline for smokeless tobacco dependence.
    Aggarwal A; Jain M; Jiloha RC
    J Postgrad Med; 2010; 56(1):50. PubMed ID: 20393259
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-cessation varenicline treatment vs post-cessation NRT: an uneven playing field.
    Rose JE
    Thorax; 2008 Aug; 63(8):751-2; author reply 752. PubMed ID: 18663077
    [No Abstract]   [Full Text] [Related]  

  • 7. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Tonstad S
    Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine gum dependence treated with varenicline--a case report.
    Garelik DA
    Nicotine Tob Res; 2010 Oct; 12(10):1041-2. PubMed ID: 20829327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically significant outcomes in smoking cessation.
    Hillman T; Rajakulasingam K; Bhowmik A
    Thorax; 2008 Aug; 63(8):752; author reply 752-3. PubMed ID: 18663078
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
    Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C
    Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
    Johnson TS
    J Am Acad Nurse Pract; 2010 Oct; 22(10):557-63. PubMed ID: 21040090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline for smoking reduction prior to cessation.
    Robey RB; Block CA; O'Rourke DJ
    JAMA; 2015 Jun; 313(22):2285. PubMed ID: 26057293
    [No Abstract]   [Full Text] [Related]  

  • 13. Varenicline for smoking reduction prior to cessation.
    Cropsey KL; Clark CB; Hendricks PS
    JAMA; 2015 Jun; 313(22):2284-5. PubMed ID: 26057292
    [No Abstract]   [Full Text] [Related]  

  • 14. A second varenicline trial.
    O'Brien CP
    Curr Psychiatry Rep; 2007 Oct; 9(5):346-7. PubMed ID: 17915071
    [No Abstract]   [Full Text] [Related]  

  • 15. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine receptor partial agonists for smoking cessation.
    Lin KW
    Am Fam Physician; 2011 Oct; 84(7):769. PubMed ID: 22010613
    [No Abstract]   [Full Text] [Related]  

  • 17. Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand.
    Harrison-Woolrych M; Ashton J
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):949-53. PubMed ID: 20602347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex difference in response to varenicline for smoking cessation.
    Gorelick DA
    Am J Psychiatry; 2015 Apr; 172(4):394-5. PubMed ID: 25827037
    [No Abstract]   [Full Text] [Related]  

  • 19. Study suggests varenicline safe and effective among adults with stable depression.
    Cinciripini PM; Karam-Hage M
    Evid Based Med; 2014 Jun; 19(3):92. PubMed ID: 24482150
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.